Gowling WLG’s global Life Sciences Group is proud to return to BIO 2025.

Our international team combines deep industry insight with comprehensive legal knowledge to help biopharma innovators protect, commercialize, and scale their discoveries across global markets. From intellectual property and transactional support to regulatory, tax and dispute resolution strategies, we’re here to help you navigate complexity at every stage of your growth.

We look forward to connecting with clients and colleagues from around the world—and welcome you to reach out in advance to book a meeting with any member of our team.

Advanced Business Development course: June 1–3

Ahead of the BIO 2025 conference, Gowling WLG professionals Patrick Duxbury and Sharmela Kalmer will be co-leading the Advanced Business Development (ABD) course—a three-day deep dive into the transactional side of biopharma deals.

A long-standing part of the BIO educational programming, this additional paid course explores the critical aspects of negotiating and executing successful life sciences transactions.

For more details, visit: bio.org